Upperton Pharma Solutions submits MHRA application for a new Annex 1–compliant sterile manufacturing facility, expanding clinical-scale CDMO capacity for biotech and pharma companies.
Strategic Partnership Strengthens UK and EU GMP Annex 1 ComplianceFREDERICK, Md., March 03, 2026 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global leader in ...
Industry experts met in Hanoi to discuss technical standards, project capacity, and sustainable development in the RHVAC ...
PLYMOUTH, MN - February 23, 2026 - PRESSADVANTAGE - ProMed continues to deliver custom silicone parts designed to meet ...
FREUDENSTADT, Germany, March 04, 2026 (GLOBE NEWSWIRE) -- SCHMID Group (NASDAQ: SHMD) has successfully delivered the first specialized InfinityLine H+ system designed for Panel-Level Packaging (PLP) ...
The project is part of the up to $30 million investment in biomanufacturing workforce development launched in September 2025. The city of New Albany pledged an additional $5 million to the project ...
Test and assembly site in Gujarat marks India’s first commercial semiconductor production following multibillion-dollar investments in US and Singapore to meet growing demand for storage and memory ...
This is my first earnings call as CEO. And as I approach nearly six months in the role, I remain very energized by the opportunity ahead of us. We have spent significant time across our global sites ...
A new optical microresonator chip keeps light circulating longer, enhancing efficiency for next-generation sensors and ...
The facility represents a combined investment of approximately $2.75 billion by Micron and its government partners, advancing semiconductor manufacturing capabilities in India. Micron Chairman, ...
SHANNON, CLARE, IRELAND, February 27, 2026 /EINPresswire.com/ -- Announcing new publication from Opto-Electronic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results